Myocardial stunning in hypertrophic cardiomyopathy: Recovery predicted by single photon emission computed tomographic thallium-201 scintigraphy  by Fine, David G. et al.
JACC Vol. 13, No. 6 1415 
May 1989:1415-8 
CASE REPORTS 
Myocardial Stunning in Hypertrophic Cardiomyopathy: Recovery 
Predicted by Single Photon Emission Computed Tomographic 
Thallium-201 Scintigraphy 
DAVID G. FINE, MD: IAN P. CLEMENT& MD, FACC, MARK J. CALLAHAN, MD, FACC 
Rochester, Minnesota 
A young woman with hypertrophic cardiomyopathy con- 
firmed by echocardiography and cardiac catheterization 
presented with chest pain and features of a large left 
ventricular aneurysm. The initial diagnosis was myocardial 
ischemia with either an evolving or an ancient myocardial 
infarction. Subsequently, verapamil therapy was associated 
with complete resolution of the extensive left ventricular 
wall motion abnormalities, normalization of left ventricular 
ejection fraction and a minimal myocardial infarction. 
Hypertrophic cardiomyopathy is characterized by asymmet- 
ric myocardial hypertrophy, myofibrillar disarray, dynamic 
left ventricular outflow obstruction and decreased left ven- 
tricular compliance (1). The electrocardiogram (ECG) fre- 
quently shows abnormal Q waves suggestive of myocardial 
infarction. Although patients with this disorder are prone to 
sudden death (2) and have described symptoms of dyspnea, 
syncope, palpitation and chest pain, myocardial infarction 
has been described only rarely. We describe extensive 
spontaneous ischemia with subsequent resolution of the 
ischemia and associated severe wall motion abnormalities in 
a young woman with hypertrophic cardiomyopathy and 
angiographically normal coronary arteries. 
Case Report 
A 32 year old white woman was admitted because of 
vague substernal heaviness associated with generalized 
weakness and exertional dyspnea lasting 12 h. She described 
three similar episodes in the past. The first was 1 year earlier 
after she received oxytocin and methylergonovine in the 
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Normal thallium uptake on single photon emission com- 
puted tomographic scintigraphy early in the hospital course 
predicted myocardial viability in the region of the aneu- 
rysm. Thus, orally administered verapamil may reverse 
spontaneous extensive myocardial ischemia in hypertrophic 
cardiomyopathy and possibly limit the extent of myocardial 
infarction in such circumstances. 
(.I Am Co11 Cardioll989;13:1415-8) 
immediate postpartum period. That episode was associated 
with hypotension, bradycardia and dizziness. An ECG at 
that time showed small Q waves in the inferolateral leads and 
ST-T wave abnormalities. The patient recovered spontane- 
ously and did’well until 3 weeks before admission, when she 
had an episode of nonexertional chest heaviness lasting 
about 2 h. Another brief episode occurred the night before 
admission. 
Many years earlier, she had been told she had a heart 
murmur. There was no history of hypertension, hyperlipide- 
mia, diabetes, tobacco use, alcohol or drug abuse, oral 
contraceptive use, syncope or palpitation and there was no 
family history of cardiac disease. 
Physical examination. The patient, a tall, slender woman, 
had a blood pressure of 92/60 mm Hg, a heart rate of 64 
beatsimin and a respiratory rate of 14 breathslmin. The apex 
beat was enlarged and dyskinetic. The jugular venous pres- 
sure was estimated to be 11 cm H,O. The first and second 
heart sounds were normal. A third heart sound was present. 
There was a grade 316 apical systolic murmur that radiated to 
the left sternal border and axilla. The remainder of the 
findings were normal. Sublingual nitroglycerin exacerbated 
the patient’s chest discomfort. 
Initial evaluation. The ECG showed normal sinus rhythm 
and evidence suggesting an acute inferolateral myocardial 
infarction (Fig. 1). A chest radiograph was normal. An 
echocardiogram (Fig. 2) revealed an apical aneurysm, asym- 
metric septal hypertrophy, hyperdynamic basal left ventric- 
01989 by the American College of Cardiology 0735.1097/89/$3,50 
1416 FINE ET AL. JACC Vol. 13, No. 6 
MYOCARDIAL STUNNING IN CARDIOMYOPATHY May 1989:1415-8 
Figure 1. Electrocardiogram on admission. 
Figure 3. Second electrocardiogram showing progression with pos- 
sible inferolateral myocardial infarction. 
ular function, systolic anterior motion of the mitral valve and 
premature aortic valve closure. Doppler examination of the 
left ventricular outflow tract was consistent with a dynamic 
obstruction with a peak gradient of 10 to IS mm Hg. Mild 
mitral regurgitation was also recorded. The overall left 
ventricular cavity size was normal, and the ejection fraction 
was estimated to be approximately 45%. The findings were 
consistent with hypertrophic obstructive cardiomyopathy 
with an apical left ventricular aneurysm. Review of an 
echocardiogram recorded at another institution 3 years ear- 
lier showed findings of hypertrophic cardiomyopathy with 
no left ventricular wall motion abnormalities. 
Serum enzymes. Serum creatine kinase was 79 III/liter on 
admission (normal, 15 to 57) with 8% MB fraction, lactate 
dehydrogenase peaked at 72 IUiliter (normal, 48 to 115) with 
isoenzyme I greater than II (33% and 31%, respectively) and 
aspartate aminotransferase was 42 IUiliter (normal, 12 to 
31). 
Hospital course. Because of further episodes of chest 
discomfort and further evolution of ECG changes (Fig. 3), 
cardiac catheterization was performed. Left ventriculogra- 
phy confirmed the asymmetric septal hypertrophy and dys- 
kinetic anterolateral, apical, apical septal and diaphragmatic 
segments. The left ventricular end-diastolic pressure was 26 
mm Hg. A mean intraventricular gradient of 22 mm Hg at 
rest was found. This increased to 45 mm Hg after ventricular 
premature beats and after amyl nitrite. The epicardial coro- 
nary arteries were entirely normal. Marked systolic com- 
pression of septal perforator vessels was seen. 
Oral administration of verapamil was begun, and the 
dose was increased to tolerance (360 mglday). Radionuclide 
angiography showed a large apical aneurysm and asymmet- 
ric septal hypertrophy. On the 8th hospital day, an echocar- 
diogram showed a persistent aneurysm but improvement in 
global left ventricular function. Single photon emission com- 
puted tomographic thallium-201 scintigraphy performed 13 
days after admission showed only slight inferoapical thin- 
ning, which was within normal limits (Fig. 4). 
Posthospital course. Radionuclide angiography per- 
formed 6 weeks after hospital discharge showed an ejection 
fraction of 83% and no evidence of aneurysm. Serial echo- 
cardiographic examinations over 4 months demonstrated 
gradual resolution of all regional wall motion abnormalities 
(Fig. 5). The patient has remained free of symptoms for more 
than a year since hospital dismissal. 
Discussion 
Figure 2. Admission echocardiogram (end-systolic frame) demon- 
strating asymmetric septal hypertrophy and an apical aneurysm. LA 
= left atrium; LV = left ventricle; RA = right atrium; RV = right 
ventricle. 
Myocardial ischemia and infarction in hypertrophic car- 
diomyopathy. This case demonstrates that spontaneous 
myocardial ischemia can result in marked wall motion ab- 
normalities mimicking extensive myocardial infarction in 
hypertrophic cardiomyopathy despite normal epicardial cor- 
onary arteries. The subsequent resolution of the wall motion 
abnormality with only a slight cardiac enzyme elevation 
demonstrated that the ischemia was reversible. This pa- 
Figure 4. Single photon emission computed tomographic thallium- 
201 scintigraphic scan performed before hospital discharge is within 
normal limits. Selected horizontal long-axis (left), vertical long-axis 
(center) and short-axis (right) images are shown. 
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Figure 5. Echocardiogram obtained 4.5 months after hospital dis- 
charge (end-systolic frame). The aneurysm present on the initial 
examination (Fig. 2) has resolved. Abbreviations as in Figure 2. 
tient’s recovery, which may have been presaged by the 
normal thallium uptake in the ischemic region, was associ- 
ated with the use of verapamil. 
Exertional chest pain in patients with hypertrophic car- 
diomyopathy is a common symptom, even in the absence of 
epicardial coronary artery disease (1). Evidence that this 
may represent myocardial ischemia comes from atrial pacing 
studies in which increased lactate production, increased 
filling pressures and signs of inadequate coronary reserve 
have been demonstrated (3-6) and from exercise studies 
showing inducible thallium perfusion defects (7). Maron (8) 
and Wailer (9) and their coworkers found transmural infarc- 
tion in seven necropsy cases of hypertrophic cardiomyopa- 
thy in which the epicardial coronary arteries were normal. 
Had the ischemia not been reversed, our patient likely 
would have been left with significant myocardial dysfunc- 
tion. Perhaps this was the mechanism by which rapidly 
progressing congestive heart failure with ventricular dilation 
developed in six of the seven patients in the series of Maron 
et al. (8). Indeed, O’Gara et al. (7) showed that 93% of 
patients with hypertrophic cardiomyopathy and depressed 
left ventricular function had evidence of myocardial scarring 
or severe ischemia with exercise thallium testing. Most 
patients in that study had reversible thallium defects after 
exercise, an indication that myocardial ischemia had disap- 
peared. The findings in our patient support the hypothesis 
that spontaneous myocardial ischemia in hypertrophic car- 
diomyopathy is reversible. Although no thallium scan was 
performed while the patient was symptomatic and no simul- 
taneous regional wall motion assessment was performed. the 
abundant uptake of thallium in the region of the mechani- 
cally “stunned” myocardium at a time when the patient was 
asymptomatic appeared to foreshadow the eventual com- 
plete myocardial recovery. 
Possible causes of acute iscbemia. The cause of acute 
myocardial ischemia in patients with hypertrophic cardiomy- 
opathy and normal coronary arteries is unknown. Cases 
demonstrating coronary emboli (8) and coronary spasm (10) 
have been reported. Myocardial compression of septal per- 
forator branches, as seen in this patient, is not uncommon in 
hypertrophic cardiomyopathy (I I). It could result in signifi- 
cant ischemia in these patients, who characteristically have 
a prolonged systolic ejection time, so that greater depen- 
dence of myocardial perfusion is placed on the relatively 
shortened diastole (6, I I). 
Abnormalities in diastolic relaxation could be responsible 
for impairment of early filling of the coronary reservoir 
(12-14). Inadequate capillary density in relation to the in- 
creased myocardial mass present (14) may result in further 
decreased oxygen extraction (5). These microcirculatory 
changes may be due to replacement by abnormal myocellu- 
lar architecture or fibrosis (15). Increased left ventricular 
filling pressure during ischemia could result in further de- 
crease in oxygen delivery secondary to microcirculatory 
compression (5). 
In the series of Maron et al. (16). 83% of the patients with 
hypertrophic cardiomyopathy had disease of the small intra- 
mural coronary arteries that was strongly associated with 
areas of fibrosis. Such small vessel disease could cause 
ischemia by reducing coronary reserve (17,lS). Tillmanns et 
al. (19) found evidence that ergometrine constricted the 
microvascular prearteriolar vessels. Cannon et al. (20) 
showed that patients with normal coronary arteries in whom 
ergonovine induced chest pain experienced chest pain after 
infusion of dipyridamole despite a more than doubling of the 
transmural flow. presumably because of abnormal small 
coronary vessels. It could be postulated that the methyler- 
gonovine received preceding the postpartum episode of our 
patient resulted in coronary spasm of either the small or the 
large coronary vessels. 
Subendocardial and possibly transmural ischemia may 
occur with left ventricular hypertrophy of other causes, 
although the mechanisms may not be identical. It has been 
shown that in other patients with left ventricular hypertro- 
phy. the small vessel coronary abnormalities are not as 
prevalent or as marked (16) and septal perforator compres- 
sion is not present (II). Additionally, the presence of an 
outflow tract obstruction seems to play a role in coronary 
reserve (6). 
Therapeutic issues. Therapy for ischemia in hypertrophic 
cardiomyopathy is no better defined than is the etiology. The 
most commonly advocated therapeutic goals have been to 
improve ventricular filling and to avoid inotropic agents. As 
in other ischemic syndromes, agents affecting the autonomic 
nervous system have been advocated by some because of its 
influence on inotropy, chronotropy and circulatory tone. 
Studies (3,13) in hypertrophic cardiomyopathy have shown 
propranolol to primarily affect heart rate and systolic ejec- 
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tion rate. Verapamil has been advocated because of its 
ability to improve diastolic filling (14). One study (21) 
showed it to increase cardiac output in some patients with 
outflow tract obstruction. Recent studies have shown ejec- 
tion fraction to remain the same (13) or decrease (14) when 
verapamil is used. Verapamil may also be beneficial if 
vasospasm is a factor. 
Conclusions. Hypertrophic cardiomyopathy can be asso- 
ciated with myocardial ischemia and infarction despite nor- 
mal epicardial coronary arteries. The clinical occurrence is 
rare, and the cause is uncertain. This is, to our knowledge, 
the first report of documented reversal of a large amount of 
ischemic myocardium in the setting of an apparent acute 
myocardial infarction in a patient with hypertrophic cardio- 
myopathy and normal coronary arteries. Treatment of such 
patients with verapamil may alleviate ischemia and may 
improve regional wall motion to a greater degree than that 
seen in patients with typical coronary artery disease. Thal- 
lium scanning may have an important prognostic role in 
these patients. 
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